Prescription Denied: A Patient's Practical Guide to Navigating and Overturning Prior Authorization

The scenario is more common than it should be. A physician completes an appointment, determines the appropriate course of treatment, and sends a prescription to the pharmacy. The patient arrives to pick it up and learns that the insurance company has placed the claim on hold. A prior authorization is required. The pharmacist cannot dispense the medication until the insurer approves it. The physician's office must be notified. The patient goes home without the medication they need.

For some conditions, this delay is an inconvenience. For others — acute infections, mental health crises, pain management situations — it can represent a genuine health risk. Yet prior authorization affects tens of millions of prescriptions in the United States every year, and the patients caught in the middle often have no clear picture of what is happening or what they can do about it.

This guide explains the mechanics of prior authorization, the rationale insurers use to justify it, and the specific steps you can take to accelerate approvals or appeal denials effectively.

What Prior Authorization Actually Is

Prior authorization (PA) — also called prior approval or precertification — is a requirement by a health insurer that a physician obtain approval before prescribing a specific medication, procedure, or service in order for that item to be covered under the patient's plan.

The authorization process typically involves the prescribing physician submitting clinical documentation to the insurer demonstrating that the requested treatment is medically necessary, appropriate for the patient's specific diagnosis, and — in many cases — that lower-cost alternatives have already been tried and found insufficient. The insurer's medical reviewers evaluate that documentation against their internal criteria and issue an approval or denial.

When approval is granted, coverage proceeds normally. When a denial is issued, the patient and physician receive a written explanation of the reasons, along with information about the appeals process.

Why Insurance Companies Require It

Understanding the insurer's perspective does not require agreeing with it, but it does make the process more navigable.

Insurers implement prior authorization as a cost-control mechanism. Many of the medications subject to PA requirements are high-cost brand-name drugs, specialty biologics, or treatments that have lower-cost therapeutic alternatives. By requiring documentation before coverage is approved, insurers aim to ensure that expensive treatments are prescribed only when clinically justified and when alternatives have been appropriately considered.

The process also addresses a genuine concern about prescribing variation. Studies have documented significant differences in prescribing patterns across regions and provider types that are not fully explained by patient population differences. Prior authorization, in theory, introduces a standardizing review layer.

From a patient's perspective, this rationale can feel abstract or irrelevant when a medication delay has immediate consequences. Both things can be true simultaneously: the cost-control logic can be defensible in aggregate while being harmful in individual cases. That tension is at the heart of ongoing policy debates about PA reform at the federal and state levels.

The Most Common Reasons Authorizations Are Denied

Knowing why denials happen is the first step toward preventing or reversing them. The most frequently cited denial rationales include:

Step therapy requirements not met. Many insurers require that patients try a specified sequence of treatments — typically starting with the least expensive options — before a higher-cost drug will be covered. If your physician prescribed a brand-name medication without documenting that first-line alternatives were tried and failed, the insurer may deny coverage on this basis.

Insufficient clinical documentation. The physician's submission may not have included the specific diagnostic codes, lab results, or clinical notes the insurer requires to establish medical necessity.

Off-label use. If a medication is prescribed for a condition that is not among the FDA-approved indications, insurers frequently require additional documentation — or may deny coverage outright, even when the off-label use is well-supported by clinical evidence.

Formulary exclusion. Some medications are simply not covered under a particular plan's formulary, and no amount of documentation will change that. In these cases, the path forward involves either a formulary exception appeal or a switch to a covered alternative.

What You Can Do: A Step-by-Step Approach

Step 1: Get the denial in writing. You are entitled to a written explanation of any denial. This document will specify the reason, the clinical criteria the insurer applied, and the timeline and process for appeal. Do not proceed without it.

Step 2: Contact your physician's office immediately. In many cases, a denial can be resolved at the administrative level before a formal appeal is necessary. The physician's office may need to submit additional documentation, correct a coding error, or provide a peer-to-peer review — a direct conversation between the prescribing physician and the insurer's medical reviewer. Peer-to-peer reviews have a documented track record of reversing denials, and requesting one is often the fastest path to resolution.

Step 3: Understand the appeals timeline. Insurers are required to provide both standard and expedited appeals processes. Standard appeals typically must be resolved within thirty days for non-urgent cases. Expedited appeals — available when a delay would seriously jeopardize your health — must generally be resolved within seventy-two hours. If your situation is urgent, explicitly request an expedited review and document your request.

Step 4: Build the clinical record. Effective appeals are documentation-intensive. Work with your physician to compile relevant medical records, prior treatment history, diagnostic results, and any peer-reviewed literature supporting the prescribed treatment. If you have already tried and failed alternative medications, that history is particularly important to document clearly.

Step 5: Submit a formal written appeal. Your denial letter will specify the submission address and required format. Write a clear, organized appeal letter that directly addresses the stated reason for denial. Attach all supporting documentation. Keep copies of everything.

Step 6: Request an external review if necessary. If your internal appeal is denied, you have the right under the Affordable Care Act to request an independent external review by a third-party organization not affiliated with the insurer. External reviewers overturn insurer decisions in a meaningful percentage of cases, and the insurer is legally bound by the external reviewer's determination.

The Role of Your Pharmacist in This Process

Pharmacists are frequently the first point of contact when a prior authorization hold is discovered, and their role extends beyond simply informing you of the delay. A pharmacist can:

• Confirm whether the denial is PA-related or involves a different coverage issue
• Contact the prescriber's office directly to initiate the PA process
• Advise on whether a therapeutic alternative on the formulary may be appropriate to discuss with your physician
• In some states, assist with emergency dispensing provisions when a delay poses a documented health risk

If you are navigating a prior authorization situation, keep your pharmacist informed. They operate within the same system and have practical experience with how specific insurers handle these cases.

When to Escalate Beyond the Insurer

If your appeals have been exhausted without resolution, additional recourse is available. Your state's insurance commissioner's office can investigate complaints about prior authorization practices. Patient advocacy organizations for specific conditions often provide navigational support and can connect you with resources. And for Medicare and Medicaid beneficiaries, dedicated ombudsman programs exist specifically to address coverage disputes.

Prior authorization is a structural feature of the American insurance landscape that is unlikely to disappear in the near term, though federal legislative efforts to reform the most burdensome aspects of the process are ongoing. Until the system changes, knowing how to work within it is the most effective tool available to patients who need their medications — and need them now.